Evidence map›Paper›PMID 25898891›Full record

ArticleThe international journal of cardiovascular imaging2016

Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.

Holger Hetterich, Axel Rominger, Lisa Walter, Maximilian Habs, Sarah Volpers, Marcus Hacker, Maximilian F Reiser, Peter Bartenstein, Tobias Saam

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05138718 (International Multicenter Trial on the Prognostic Value of Arterial 18F-FDG PET Imaging in Patients With History of Myocardial Infarction), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05138718 unknown statusnot on this mapstarted 2021, after this paper: background citation

International Multicenter Trial on the Prognostic Value of Arterial 18F-FDG PET Imaging in Patients With History of Myocardial Infarction

Typeobservational_patient_registrySponsorInternational Atomic Energy AgencyRan2021 to 2026Enrolled2,041ConditionsHistory of Myocardial InfarctionArms18F-FDG PET/CT
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Could FDG-PET imaging play a role in the detection of progressing atherosclerosis in HIV-infected patients?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  10. Article
  11. Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018 · on this map
    Article
  12. From inflammation to calcification in atherosclerosis.European journal of nuclear medicine and molecular imaging · 2017
    Article
  13. Article
  14. Cardiovascular imaging 2015 in the International Journal of Cardiovascular Imaging.The international journal of cardiovascular imaging · 2016
    Review
  15. Topical issue: multimodality imaging in atherosclerosis.The international journal of cardiovascular imaging · 2016
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Holger HetterichInstitute of Clinical Radiology, Ludwig-Maximilians-University Hospital, Marchioninistr. 15, 81377, Munich, Germany. Holger.Hetterich@med.uni-muenchen.de.
Axel RomingerDepartment of Nuclear Medicine, Ludwig-Maximilians-University Hospital, Munich, Germany.
Lisa WalterInstitute of Clinical Radiology, Ludwig-Maximilians-University Hospital, Marchioninistr. 15, 81377, Munich, Germany.
Maximilian HabsDepartment of Neurology, Ludwig-Maximilians-University Hospital, Munich, Germany.
Sarah VolpersDepartment of Nuclear Medicine, Ludwig-Maximilians-University Hospital, Munich, Germany.
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Maximilian F ReiserInstitute of Clinical Radiology, Ludwig-Maximilians-University Hospital, Marchioninistr. 15, 81377, Munich, Germany.
Peter BartensteinDepartment of Neurology, Ludwig-Maximilians-University Hospital, Munich, Germany.
Tobias SaamInstitute of Clinical Radiology, Ludwig-Maximilians-University Hospital, Marchioninistr. 15, 81377, Munich, Germany.
Ludwig-Maximilians-Universität München · DEMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to assess the impact of cardiovascular risk factors and plaque inflammation on the progression of atherosclerosis as assessed by positron emission tomography/computed tomography (PET/CT) imaging with (18)F-radiolabled fluorodeoxyglucose ((18)F-FDG). This study was designed as a retrospective cohort study. Patients who received a (18)F-FDG PET/CT scan and follow-up scan 9-24 months later without systemic inflammation or steroid medication were eligible for the study. (18)F-FDG PET/CT included a full diagnostic contrast enhanced CT scan. Cardiovascular risk factors and medication were documented. Calcified plaque volume, lumen area and (18)F-FDG uptake, quantified by the target-to-background ratio (TBR), were measured in the carotid arteries, aorta and iliac arteries. Influence of cardiovascular risk factors and vessel wall inflammation on atherosclerotic disease progression was analyzed. Ninety-four patients underwent baseline and follow-up whole body (18)F-FDG PET/CT (mean follow-up time 14.5 ± 3.5 months). Annualized calcified plaque volume increased by 15.4 % (p < 0.0001), carotid and aortic lumen area decreased by 10.5 % (p < 0.0001) and 1.7 % (p = 0.045). There was no significant difference in (18)F-FDG uptake at baseline and follow-up (mean TBR 1.44 ± 0.18 vs. 1.42 ± 0.19, p = 0.18). Multiple linear regression analysis identified hypertension as an independent predictor for total, aortic and iliac calcified plaque volume progression (all p < 0.04). Carotid lumen reduction was predicted by hypercholesterolemia (p = 0.008) while aortic lumen reduction was associated with BMI and mean (18)F-FDG uptake (p ≤ 0.005). Furthermore we observed a dose response relationship between the number of cardiovascular risk factors and calcified plaque volume progression in the aorta (p = 0.03). Findings from this study provide data on the natural history of atherosclerotic disease burden in multiple vascular beds and emphasize the value of morphological and physiologic information provided by (18)F-FDG PET/CT imaging.

Indexed as

Positron-Emission TomographyTomography, X-Ray ComputedAgedAged, 80 and overAortaAortic DiseasesAortographyArteriesAtherosclerosisCarotid ArteriesCarotid Artery DiseasesDisease ProgressionFemaleFluorodeoxyglucose F18HumansIliac ArteryFluorodeoxyglucose F18RadiopharmaceuticalsAtherosclerosisCardiovascular risk factorsFDGPET/CTPlaque imaging

Identifiers

PMID25898891
OpenAlexW1971164984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.